Adenocarcinoma of the Rectum Completed Phase 2 Trials for Leucovorin (DB00650)

IndicationStatusPhase
DBCOND0028688 (Adenocarcinoma of the Rectum)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00100841Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal CancerTreatment
NCT00707889Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal CancerTreatment
NCT00942266Vorinostat, Fluorouracil, and Leucovorin Calcium in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous TreatmentTreatment